Midatech Pharma PLC (LSE:MTPH) - Share price - Overview

Stock Report

Midatech Pharma PLC MTPH

Last Price
GBX30.00

Day Change
0.00|0.00%

As of 25/05/2018
14:35:00 BST | GBX
Minimum 15 Minutes Delay.

Last Close30.00p
Day Range30.05 - 31.89
Mkt Cap18.32Mil
52-Wk Range23.00 - 103.47
Yield %-
ISINGB00BRTL9B63
Volume92,704
P/E-1.03
P/S0.02
P/CF-0.01

Share Price

Total Returns 25/05/2018

 Chg (%)  
More ...
Midatech Pharma PLC27.66 
FTSE 100 TR GBP5.34
 
Financials
201520162017
More ...
Income Statement
Turnover1.386.927.60
Operating Profit-12.92-19.17-16.08
Net Profit-10.10-20.16-16.06
Reported EPS-36.00-56.00-31.00
Balance Sheet
Current Assets20.3322.3018.58
Non Current Assets43.7134.3930.64
Total Assets64.0456.6949.22
Current Liabilities9.109.358.36
Total Liabilities17.1510.9714.55
Total Equity46.8945.7234.68
Cash Flow
Operating Cash Flow-13.07-14.74-14.41
Net Change in Cash-14.170.97-4.15
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
17/10/2017PurchaseDr. Simon Turton50.0060,00030,000.00
17/10/2017PurchaseMr. Rolf Stahel50.0050,00025,000.00
17/10/2017PurchaseMr. John Joseph Johnston50.0040,00020,000.00
17/10/2017PurchaseDr. James Neil Phillips50.0020,00010,000.00

Company Profile

Midatech Pharma PLC is a nanomedicine company engaged in the development and commercialization of multiple therapeutic products to enhance the delivery of medicines in diseases with high unmet medical needs.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 29/05/2018

Annual Report
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-42.14
Op Mrgn-2.12
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. Paul Protopapas
Non-Executive DirectorMr. Michele Luzi
Non-Executive DirectorDr. Simon de Vries
Non-Executive DirectorDr. Simon Turton
Non-Executive Director, ChairmanMr. Rolf Stahel
Non-Executive DirectorMr. John Joseph Johnston
Executive Director, Chief Executive OfficerDr. James Neil Phillips
Executive Director, Finance Director and Company SecretaryMr. Nicholas John Robbins-Cherry
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.